Rubis Sca RUBIS ORD SHS/ FR0013269123 /
| 2024-05-24 6:13:16 PM | Chg. - | Volume | Bid5:40:11 PM | Ask5:40:11 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 32.24EUR | - | 378,132 Turnover: 107,383.74 |
-Bid Size: - | -Ask Size: - | 2.31 bill.EUR | - | 6.52 |
GlobeNewswire
2023-11-08
Hemper and 40 Tons Launch Rolling Tray Collab to Raise Awareness for Incarcerated Individuals
Newsfile Corp
2023-10-04
The New Immersive Exhibition, A Portal for Healing, Opening at theART-Dept. In West Hollywood Octobe...
GlobeNewswire
2021-05-21
Athenex Announces Klisyri® (tirbanibulin) Receives Positive CHMP Opinion from the European Medicines...
GlobeNewswire
2021-05-17
Athenex, Texas Children’s Cancer Center, and the Center for Cell and Gene Therapy at Baylor College ...
GlobeNewswire
2021-05-04
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineere...
GlobeNewswire
2021-04-27
Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021
GlobeNewswire
2021-03-01
Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update
GlobeNewswire
2021-03-01
Athenex Receives FDA Complete Response Letter for Oral Paclitaxel Plus Encequidar for the Treatment ...
GlobeNewswire
2021-02-22
Athenex to Provide a Corporate and Financial Update for the Fourth Quarter and Full Year 2020 on Mar...
GlobeNewswire
2021-02-18
Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin
GlobeNewswire
2021-02-11
Athenex Announces New England Journal of Medicine Publication of Phase III Data on the Efficacy and ...
GlobeNewswire
2020-12-15
Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on ...
GlobeNewswire
2020-12-09
Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel a...
GlobeNewswire
2020-12-02
Athenex Pharmaceutical Division and Ingenus Pharmaceuticals Announce Availability of Liquid, Ready t...
GlobeNewswire
2020-11-17
Athenex Announces Data on Oral Paclitaxel and Encequidar to be Presented at the 2020 San Antonio Bre...
GlobeNewswire
2020-11-05
Athenex, Inc. Reports Third Quarter Ended September 30, 2020 Financial Results and Provides Corporat...
GlobeNewswire
2020-10-22
Athenex, Inc. to Report Third Quarter 2020 Earnings Results on November 5, 2020
GlobeNewswire
2020-10-12
Axis Therapeutics Announces Research Collaboration with PharmaEssentia for Development of TCR-T Cell...
